OPT vs SKYE
Comparison between Opthea Ltd (OPT, Company) and Skye Bioscience Inc (SKYE, Company).
Both OPT and SKYE are from the Healthcare sector.
OPT vs SKYE - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
OPT
$22M
Winner
SKYE
$22M
Max Drawdown
OPT
N/A
SKYE
99.96%
Sharpe Ratio
Winner
OPT
0.00
SKYE
-1.15
5Y Beta
OPT
N/A
SKYE
1.49
Industry
OPT
Biotechnology
SKYE
Biotechnology
P/E Ratio
Winner
OPT
-4.62
SKYE
-0.35
Forward P/E
OPT
6.73
SKYE
N/A
PEG Ratio
OPT
N/A
SKYE
-0.01
5Y EPS CAGR
OPT
N/A
SKYE
-21.69%
Debt to Equity
OPT
156.18%
Winner
SKYE
0.00%
P/S Ratio
OPT
151.40
SKYE
N/A
P/B Ratio
OPT
-1.03
SKYE
N/A
OPT vs SKYE - Historical Returns
Returns include dividend reinvestment.
1M
Winner
OPT
+0.00%
SKYE
-16.30%
3M
Winner
OPT
+0.00%
SKYE
-33.97%
6M
Winner
OPT
+0.00%
SKYE
-42.54%
1Y
OPT
N/A
SKYE
-83.93%
5Y(CAGR)
OPT
N/A
SKYE
-56.84%
10Y(CAGR)
OPT
N/A
SKYE
-40.95%
Max(CAGR)
Winner
OPT
+0.00%
SKYE
-49.35%
OPT vs SKYE - Annual Returns (2015 - 2026)
Returns include dividend reinvestment.
| Year | OPT | SKYE |
|---|---|---|
| 2026 | +0.00% | -33.92% |
| 2025 | N/A | -73.69% |
| 2024 | N/A | +4.04% |
| 2023 | N/A | -34.85% |
| 2022 | N/A | -70.55% |
| 2021 | N/A | +29.68% |
| 2020 | N/A | -72.41% |
| 2019 | N/A | -65.53% |
| 2018 | N/A | +116.22% |
| 2017 | N/A | -56.57% |
| 2016 | N/A | -52.81% |
| 2015 | N/A | -86.41% |
OPT vs SKYE Drawdown Comparison
The maximum drawdown for SKYE was -99.96%, occurring on Mar 27, 2026. This drawdown has not yet recovered.
The current SKYE drawdown is -99.96%.
| Rank | OPT | SKYE |
|---|---|---|
| #1 | N/A | -99.96% Apr 7, 2015 - Mar 27, 2026 |
Correlation
Correlation between OPT and SKYE is 0.00 which considered as a very weak or no correlation - the stocks move independently of each other.
0.00
-101
Select Stocks to Compare
Popular: OPT vs SPYSKYE vs SPY
More Comparisons
Compare with similar stocks